Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switch Risperidone to Aripiprazole in Early Stage of Pharmacotherapy of Schizophrenia

NCT00352339 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT00352339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00352339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switch Risperidone to Aripiprazole in Early Stage of Pharmacotherapy of Schizophrenia
Lead sponsor
Inje University
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2006
Completion date
December 31, 2010
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia